| Item Type | Name |
|
Academic Article
|
Nonfunctioning islet cell carcinoma of the pancreas.
|
|
Academic Article
|
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
|
|
Academic Article
|
Islet cell carcinoma of the pancreas. A study of 98 patients.
|
|
Academic Article
|
Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
|
|
Concept
|
Survival Analysis
|
|
Academic Article
|
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
|
|
Academic Article
|
Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
|
|
Academic Article
|
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
|
|
Academic Article
|
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
|
|
Academic Article
|
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
|
|
Academic Article
|
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma.
|
|
Academic Article
|
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
|
|
Academic Article
|
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
|
|
Academic Article
|
Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer.
|
|
Academic Article
|
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
|
|
Academic Article
|
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
|
|
Academic Article
|
Paclitaxel in the treatment of carcinoma of the esophagus.
|
|
Academic Article
|
Oral etoposide for patients with advanced adenocarcinoma of the pancreas.
|
|
Academic Article
|
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
|
|
Academic Article
|
Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review.
|
|
Academic Article
|
Gastric carcinoma.
|
|
Academic Article
|
Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
|
|
Academic Article
|
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.
|
|
Academic Article
|
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
|
|
Academic Article
|
The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
|
|
Academic Article
|
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma.
|
|
Academic Article
|
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
|
|
Academic Article
|
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
|
|
Academic Article
|
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
|
|
Academic Article
|
Proposed modification of nodal status in AJCC esophageal cancer staging system.
|
|
Academic Article
|
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
|
|
Academic Article
|
Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
|
|
Academic Article
|
Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.
|
|
Academic Article
|
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.
|
|
Academic Article
|
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
|
|
Academic Article
|
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.
|
|
Academic Article
|
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
|
|
Academic Article
|
Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
|
|
Academic Article
|
Therapy of localized gastric cancer: preoperative and postoperative approaches.
|
|
Academic Article
|
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
|
|
Academic Article
|
Chemotherapy is more active against proximal than distal gastric carcinoma.
|
|
Academic Article
|
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
|
|
Academic Article
|
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
|
|
Academic Article
|
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
|
|
Academic Article
|
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
|
|
Academic Article
|
Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
|
|
Academic Article
|
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus.
|
|
Academic Article
|
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.
|
|
Academic Article
|
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
|
|
Academic Article
|
[Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
|
|
Academic Article
|
Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma.
|
|
Academic Article
|
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.
|
|
Academic Article
|
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.
|
|
Academic Article
|
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.
|
|
Academic Article
|
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
|
|
Academic Article
|
Combined modality therapy of localized gastric and esophageal cancers.
|
|
Academic Article
|
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
|
|
Academic Article
|
Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
|
|
Academic Article
|
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
|
|
Academic Article
|
Gastric cancer: advances in adjuvant and adjunct therapy.
|
|
Academic Article
|
Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer.
|
|
Academic Article
|
Advanced gastroesophageal carcinoma: an update on the current therapeutic landscape.
|
|
Academic Article
|
Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
|
|
Academic Article
|
Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer.
|
|
Academic Article
|
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
|
|
Academic Article
|
Medical management of gastric cancer: a 2014 update.
|
|
Academic Article
|
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
|
|
Academic Article
|
Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma.
|
|
Academic Article
|
Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
|
|
Academic Article
|
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer.
|
|
Academic Article
|
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
|
|
Academic Article
|
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.
|
|
Academic Article
|
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma.
|
|
Academic Article
|
Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.
|
|
Academic Article
|
The ypT category does not impact overall survival in node negative gastric cancer.
|
|
Academic Article
|
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer.
|
|
Academic Article
|
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.
|
|
Academic Article
|
Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients.
|
|
Academic Article
|
Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
|
|
Academic Article
|
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
|